MENU
ABUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Arbutus Biopharma (ABUS) Earnings Date & Reports
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ABUS is expected to report earnings to fall 103.45% to -2 cents per share on July 30
Q2'26
Est.
$-0.03
Q1'26
Beat
by $0.91
Q4'25
Missed
by $0.14
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of 87 cents, beating the estimate of -3 cents. With 1.12M shares outstanding, the current market capitalization sits at 839.54M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of drugs to improve the treatment of cancer
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
19
Web
http://www.arbutusbio.com